Pfizer stock: buy or sell

PFE stock price: $36.55 0.19% At close on Jan 22nd, 2021

Updated on:
Jan 25th, 2021

2

Pfizer stock brief

  • Pfizer closed last Friday at $36.55 after just changing a 0.19%.
  • Pfizer is presenting its earnings report on Tuesday
  • Pfizer Inc. develops, manufactures, and sells healthcare products worldwide.

Should I buy Pfizer stock?

All successful traders recommend adhering to a trading strategy and not make decisions based on subjective opinions, rumors or feelings. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best

Is $PFE stock a buy?

In the current situation of Pfizer there is not any eligible buy setup. This doesn't mean $PFE will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems

Should I sell Pfizer stock?

"To sell or not to sell", if you are holding Pfizer stock?. In the same way as when we have to buy shares, determining when is the best time to sell is not a whimsical decision, and we must use our own trading style. We like very simple setups to guide us on when is the best time to sell a stock. Be aware that these setups are not intended for selling short $PFE stock

As a rule of thumb, you must never hold an open trade that generates losses greater than those expected at the time of purchase. The timing to sell your stock must always be dictated by the stop-loss (automatic or manual)

Is it time to sell Pfizer stock?

Currently, Pfizer stock doesn't match any of our preferred sell setups, so if you own Pfizer shares and your operation is in profit probably is not time to sell now

Pfizer ratings

In the last 30 days, just one rating was published for Pfizer

Pfizer analysts' ratings - Last month
Brokerage firmRating
Dec 29th, 2020
Royal Bank of Canada Neutral

Pfizer stock analysis

SMAs overview

PFE stock SMAs chart

Supports and resistances

The current resistances are:

  • R1: $36.72 (0.47% above)
  • R2: $37.30 (2.05% above)
  • R3: $37.35 (2.19% above)
  • The current support levels are:

  • S1: $36.54 (-0.03% below)
  • S2: $36.48 (-0.19% below)
  • S3: $36.33 (-0.60% below)
  • Bollinger bands

    The current distance between the upper and lower bands is 3.30%, and this means that price volatility is at very low levels. Reduced volatility is often the antecedent to a sharp movement (up or down), so we must be alert and manage our buy or sell orders appropiately

    PFE stock Bollinger Bands chart

    Relative strength index

    The RSI dropped below the overbought level of 70 in mid-December after just crossing to the overbough zone for 1 day (weak signal). The RSI value last Friday was 42.3. Since RSI lost the overbought zone, Pfizer stock sank a 12.41%

    PFE stock RSI chart

    Pfizer stock price history

    Pfizer went public on Jun 1st, 1972 at $0.00 per share1. Since then, PFE stock surged by -, with an average of 0.00% per year. An investment of thousand dollars on Jun 1972 would be valued $inf nowadays.

    1: Adjusted price after possible price splits or reverse-splits

    PFE stock price history chart

    Price target for Pfizer stock

    How much a stock will be priced tomorrow or next week is quite unpredictable. Banks and financial organisations post their analysis predicting how a particular stock will performance in the future.

    The following table shows the price target posted by brokerage institutions over the last 30 days. If you are a small investor you must not trade based on these forecasts.

    There is just one price target available for Pfizer that predicts a price of $42.00.

    Pfizer stock price predictions
    Brokerage firmPrice target
    Dec 29th, 2020
    Royal Bank of Canada $42.00

    Earnings and financials

    Pfizer ($PFE) is posting Q4 financial report on Tuesday. Wall Street predicts of $0.52, compared to Q3 that made $0.72.

    Earnings reporting day has an additional risk for traders as the data posted can jump up or down the stock price with very low liquidity and not respecting your buy/stop-loss orders. You can obtain more details about the earnings call and the financial reports on the Investor Relations section of its website: http://www.pfizer.com.

    Last October, Pfizer Inc. ($PFE) reported adjusted EPS for that matched Market expectations. Quarterly EPS was $0.72 per share vs the estimates of $0.71. Reported sales were $12.1 billion, aligned with analysts' forecasts as well.

    Compared to the same quarter one year ago, EPS was $0.75, so posted EPS is a reduction of -4.00%. Looking at revenue, figures barely moved compared to $126.8B same quarter 12 months ago.

    Pfizer performance

    PFE performance compared
    Company1m3m6m
    Pfizer ($PFE) -1.80% 5.00% 3.30%

    Disclaimer:
    The viewpoints expressed in this article are personal and should not be followed as recommendations for you to buy or sell shares. The author of this article does not have an understanding of the particular positions of the reader, his or her financial statements or his or her own best interests at any given time. All users should speak with their financial advisor before buying or selling any securities Viewpoints are posted for informational reasons only

    Pfizer summary

    Friday, January 22nd, 2021
    Open$36.32
    Close$36.55
    Day range$36.25 - $36.83
    Previous close$36.48
    Session gain0.19%
    Average true range$0.66
    50d mov avg$37.72
    100d mov avg$36.08
    200d mov avg$35.02
    Earnings dateJanuary 26th, 2021

    Frequently asked questions

    What is Pfizer stock symbol?

    Pfizer Inc. is a public company trading in the US stock market with the PFE symbol

    Is Pfizer stock a buy or sell?

    Pfizer had one rating in the last four weeks Read the article to get additional tips on trading PFE stock.

    Will PFE go up?

    Pfizer had different price forecasts posted by analysts in the last 4 weeks forecasting the target price to $42.00. That is a 14.91% than the current price ($36.55).